- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Search trials
Studi clinici sponsorizzati da Emergent Product Development Seattle LLC
Totale 14 risultati
-
Emergent Product Development Seattle LLCTerminatoMicosi fungoide | Sindrome di SézaryStati Uniti, Spagna, Francia, Germania, Italia
-
PfizerEmergent Product Development Seattle LLCCompletatoArtrite reumatoideStati Uniti, Canada
-
PfizerEmergent Product Development Seattle LLCCompletatoArtrite reumatoide attivaStati Uniti, Canada, Serbia, Giappone, Spagna, Polonia, Ungheria, Argentina, Chile, Messico
-
PfizerEmergent Product Development Seattle LLCCompletatoLupus Eritematoso, SistemicoStati Uniti
-
PfizerEmergent Product Development Seattle LLCCompletatoArtrite, reumatoideGiappone
-
Wyeth is now a wholly owned subsidiary of PfizerEmergent Product Development Seattle LLCTerminato
-
Wyeth is now a wholly owned subsidiary of PfizerEmergent Product Development Seattle LLCTerminatoLupus eritematoso sistemicoStati Uniti
-
GE HealthcarePharmaceutical Product Development, LLCCompletatoMalattia coronarica (CAD)Stati Uniti, Germania, Svizzera, Canada, Olanda, Francia, Finlandia
-
Seattle Children's HospitalCompletatoDolore | Infante, neonato, malattie
-
Milliken Healthcare Products, LLCU.S. Army Medical Research and Development Command; Criterium, Inc.CompletatoBrucia | Ustione cutanea che richiede innesto cutaneoStati Uniti
-
Medical University of South CarolinaMerck Sharp & Dohme LLC; FDA Office of Orphan Products DevelopmentCompletatoOsteoporosiStati Uniti
-
Medical University of South CarolinaMerck Sharp & Dohme LLC; FDA Office of Orphan Products DevelopmentCompletatoFratture | Osteoporosi giovanile | Bassa densità osseaStati Uniti
-
Januario Castro, M.D.FDA Office of Orphan Products Development; Memgen, LLCTerminatoLeucemia linfatica cronica | Piccolo linfoma linfociticoStati Uniti
-
Georgetown UniversityJohns Hopkins Bloomberg School of Public Health; United States Agency for International... e altri collaboratoriReclutamentoProfilassi orale pre-esposizione (PrEP) | Cabotegravir iniettabile a lunga durata d'azione per la PrEPMalawi